Ocean Allyson J 4

What Happened

• Ocean Allyson J, a director of NovoCure Ltd (NVCR), received grants on 2026-06-03 totaling 28,609 awards: 11,610 restricted stock units (RSUs) and 16,999 derivative awards. Both grants were reported at $0.00 per share (no cash paid). These are compensation awards, not open‑market purchases or sales.

Key Details

• Transaction date: 2026-06-03; Form 4 filed: 2026-06-05 (appears timely).
• Grants reported:
  • 11,610 RSUs (reported as acquisition A) — $0.00 per share.
  • 16,999 derivative awards (reported as acquisition A, derivative) — $0.00 per share.
• Shares owned after transaction: not disclosed in the filing.
• Footnotes:
  • F1: RSUs scheduled to vest 100% on the earlier of (i) first anniversary of the grant or (ii) the day before the Company’s 2027 annual meeting.
  • F2: Options to buy ordinary shares will fully vest on the earlier of (i) first anniversary of the grant or (ii) the day before the 2027 annual meeting.
• Transaction type code: A = Award/Grant. No indication of tax withholding, 10b5‑1 plan, or late filing in the report.

Context

• These awards are compensation grants. RSUs and the noted derivative (options) vest based on the schedule in the footnotes; the filing reports no immediate sale or purchase of shares.
• Because no cash was paid and the awards typically vest over time, this is not a market signal like an open‑market buy or sale but rather insider compensation disclosure.